COVID-19 patients has come a long way since Canada treated its first patient in hospital in January.“All the things that we were doing were merely supporting the failing lungs through the use of oxygen or ventilators,” said Dr.
Daniel Niven, an intensive care physician and an assistant professor at the University of Calgary.More than six months later and thanks to a flurry of international research, some new therapies have emerged.
In recent weeks, doctors say an anti-inflammatory steroid, dexamethasone, has become standard care in intensive care units across the country.
Cheap drug could help save lives from coronavirus, early study results show “Prior to the last few weeks, you might have only had about 50 per cent of doctors using.